• 1. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Peptides
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Peptides

Professional Introduction to H-Pro-Tyr-NH2·HCl (CAS No. 52329-46-1)

H-Pro-Tyr-NH2·HCl, a compound with the chemical name N-Hydroxyprolyltyrosine hydrochloride, is a synthetic peptide derivative that has garnered significant attention in the field of pharmaceutical research and biotechnology. This compound, identified by its unique CAS No. 52329-46-1, is widely recognized for its potential applications in drug development, particularly in the synthesis of bioactive peptides and as a precursor in the production of therapeutic agents.

The structure of H-Pro-Tyr-NH2·HCl consists of a proline (Pro) and tyrosine (Tyr) residue linked by an amide bond, with a hydroxyl group (-OH) attached to the proline moiety and a terminal amino group (-NH2) at the tyrosine residue. The hydrochloride salt form enhances its solubility in aqueous solutions, making it more suitable for various biochemical applications.

In recent years, there has been growing interest in the development of novel peptide-based therapeutics due to their high specificity and low toxicity. H-Pro-Tyr-NH2·HCl has emerged as a key intermediate in the synthesis of complex peptides, including those used in targeted cancer therapies and anti-inflammatory agents. Its role in peptide coupling reactions has been extensively studied, particularly in solid-phase peptide synthesis (SPPS), where it serves as a building block for constructing larger peptide chains.

One of the most compelling aspects of N-Hydroxyprolyltyrosine hydrochloride is its involvement in enzymatic reactions and post-translational modifications. The hydroxyl group on the proline residue can participate in hydrogen bonding networks, influencing the conformational stability of peptides. This property makes it particularly valuable in designing peptides with specific biological activities, such as those targeting protein-protein interactions or modulating enzyme function.

Recent research has highlighted the potential of H-Pro-Tyr-NH2·HCl in the development of peptide-based vaccines. Its ability to form stable complexes with other biomolecules has been exploited to create multivalent vaccine candidates that can elicit robust immune responses. Studies have demonstrated its efficacy in formulations designed to enhance antigen presentation and T-cell activation, paving the way for novel immunotherapeutic strategies.

The pharmaceutical industry has also explored N-Hydroxyprolyltyrosine hydrochloride as a component in drug delivery systems. Its amphiphilic nature allows it to form micelles or nanoparticles when combined with other hydrophobic and hydrophilic compounds. These nanoformulations have shown promise in improving the bioavailability and targeted delivery of therapeutic agents, particularly for drugs that require protection from enzymatic degradation or have poor solubility.

Moreover, CAS No. 52329-46-1 has been utilized in academic research to investigate the mechanisms of peptide-protein interactions. Its well-defined structure and reactivity make it an ideal candidate for computational modeling and experimental studies aimed at understanding how peptides bind to their targets. Such insights are crucial for designing next-generation therapeutics with enhanced efficacy and reduced off-target effects.

In conclusion, H-Pro-Tyr-NH2·HCl represents a versatile and valuable compound in modern pharmaceutical research. Its applications span from serving as a key intermediate in peptide synthesis to being a critical component in drug delivery systems and vaccine development. The ongoing exploration of its biological activities and structural properties continues to expand its potential uses, making it an indispensable tool for researchers striving to innovate in the field of biomedicine.

• 1948-71-6(N-Acetyl-L-tyrosine Amide)
• 19361-52-5(Ac-Phe-Tyr-NH2)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)